TAM
IMGN

Tocqueville Asset Management’s Immunogen Inc IMGN Stock Holding History

Tocqueville Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-21,400
Closed -$254K – 1336
2014
Q2 		$254K Hold
21,400
– – ﹤0.01% 912
2014
Q1 		$320K Sell
21,400
-8,000
-27% -$126K ﹤0.01% 686
2013
Q4 		$431K Hold
29,400
– – 0.01% 611
2013
Q3 		$500K Buy
+29,400
New +$517K 0.01% 640

Other funds holding IMGN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Tocqueville Asset Management's IMGN Position: Q3 2014 in Review

Tocqueville Asset Management sold out of Immunogen Inc (IMGN) in Q3 2014, closing a stake of 21,400 shares — an estimated $254K sold.

Tocqueville Asset Management first reported a position in IMGN in Q3 2013 and held it in 4 quarters. The position peaked at $500K in Q3 2013. 141 funds tracked by Wall St. Rank hold IMGN as of Q3 2014.

  • Tocqueville Asset Management reported no remaining Immunogen Inc position as of Q3 2014 after selling out during the quarter.
  • Tocqueville Asset Management sold 21,400 Immunogen Inc shares in Q3 2014, an estimated $254K.
  • Tocqueville Asset Management first reported a position in Immunogen Inc in Q3 2013 and held it in 4 quarters.
  • Tocqueville Asset Management's Immunogen Inc position peaked at $500K in Q3 2013.
  • 141 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2014.

Based on Tocqueville Asset Management's 13F filing for Q3 2014, filed 30 Oct 2014.